Erythropoeitin receptor function and expression in epithelial ovarian carcinoma

Gynecologic Oncology

Volumn 99, Issue 3, 2005, Pages 571-577

  McBroom, John W ^a   Acs, Geza ^b   Rose, G Scott ^c   Krivak, Thomas C ^d   Mohyeldin, Ahmed ^e   Verma, Ajay ^e  

^a TRIPLER ARMY MEDICAL CENTER   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^c WALTER REED ARMY MEDICAL CENTER   (United States)

^d DAVID GRANT MEDICAL CENTER   (United States)

^e Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

Author keywords

Erythropoietin receptor; Ovarian carcinoma

Indexed keywords

CISPLATIN; ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; PACLITAXEL; PROTEIN HYDROLYSATE; ANTINEOPLASTIC AGENT;

ARTICLE; CANCER CELL CULTURE; CELL LINE; CONTROLLED STUDY; CYTOTOXICITY; DRUG CYTOTOXICITY; EPITHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALIGNANT NEOPLASTIC DISEASE; OVARY CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; STATISTICAL SIGNIFICANCE; WESTERN BLOTTING; BIOSYNTHESIS; CYSTADENOCARCINOMA; CYSTADENOMA; DRUG SCREENING; FEMALE; METABOLISM; OVARY TUMOR; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; BLOTTING, WESTERN; CELL LINE, TUMOR; CISPLATIN; CYSTADENOCARCINOMA, SEROUS; CYSTADENOMA, SEROUS; DRUG SCREENING ASSAYS, ANTITUMOR; EPITHELIAL CELLS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; OVARIAN NEOPLASMS; RECEPTORS, ERYTHROPOIETIN;

EID: 28044441545     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2005.06.038     Document Type: Article

References (27)

1. A. Jemal, A. Thomas, T. Murray, and M. Thun CA Cancer J. Clin. 52 1 2002 (Jan-Feb) 23 47
2. D. Creasman Clinical gynecologic oncology 5th ed. 1997 Mosby-Year Book St. Louis (MO) 284
3. S. Pecorekku Carcinoma of the ovary S. Pecorelli W.T. Creasman F. Pettersson FIGO Annual Report on the Results of Treatment in Gynaecological Cancer vol. 23 1998 Isis Medical Media Limited Oxford 75 102
4. R.F. Ozols, P.E. Schwartz, and P.J. Eifel Ovarian cancer, fallopian tube carcinoma and peritoneal carcinoma V.T. DeVita S. Hellman R.A. Rosenberg Cancer: principles and practice of oncology 6th ed. 2001 Lippincott Williams and Wilkins 1597 1632
5. B. Quirt, C. Robeson, C. Lau, M. Kovac, S. Burdette-Radoux, and S. Dolan Epoetin alpha therapy increases hemoglobin levels and improves quality of life in patients with cancer-related anemia who are not receiving chemotherapy and patients with anemia who are receiving chemotherapy J. Clin. Oncol. 19 21 2001 (Nov 1) 4126 4134
6. M. Dicato, C. Duhem, G. Berchem, and F. Ries Clinical benefit from erythropoietin Curr. Opin. Oncol. 12 4 2000 (Jul) 297 302
7. H. Oettle, H. Riess, J.D. Raguse, J. Bier, and H.J. Gath Recombinant human erythropoietin in the treatment of head and neck tumor anaemia Int. J. Oral Maxillofac. Surg. 30 2 2001 (Apr) 148 155
8. C. Kasper Recombinant human erythropoietin in the treatment of anemic patients with hematological malignancies Ann. Hematol. 80 6 2001 (Jun) 319 329
9. D.M. Wojchowski, R.C. Gregory, C.P. Miller, A.K. Pandit, and T.J. Pircher Signal transduction in the erythropoietin receptor system Exp. Cell Res. 253 1 1999 (Nov 25) 143 156
10. L.T. Goodnough Erythropoietin therapy versus red cell transfusion Curr. Opin. Hematol. 8 6 2001 (Nov) 405 410
11. T.J. Littlewood Erythropoietin for the treatment of anemia associated with hematological malignancy Hematol. Oncol. 19 1 2001 (Mar) 19 30
12. T.J. Littlewood, E. Bejetta, J. Nortier, E. Vercammen, B. Rapport for the Epoetin Alfa Study Group Effects of epoetin alpha on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trial J. Clin. Oncol. 19 11 2001 (Jun 1) 2865 2874
13. J.A. Glaspy Hematopoietic management in oncology practice: Part 2. Erythropoietic factors Oncology (Huntingt) 17 12 2003 (Dec) 1724 1730 [discussion 1731-2, 1735, 1739]
14. M. Mittelman, D. Neumann, A. Peled, P. Kanter, and N. Haran-Ghera Erythropoietin induces tumor regression and antitumor immune responses in murine myeloma models Proc. Natl. Acad. Sci. U. S. A. 98 9 2001 (Apr 24) 5181 5186
15. G. Acs, P. Zhang, T. Rebbeck, P. Acs, and A. Verma Immunohistochemical expression of erythropoietin and erythropoietin receptor in breast carcinoma Cancer 95 5 2002 (Sep 1) 969 981
16. M.O. Arcasoy, K. Amin, A.F. Karayal, S.C. Chou, J.A. Raleigh, and M.A. Varia Functional significance of erythropoietin receptor expression in breast cancer Lab. Invest. 82 7 2002 (Jul) 911 918
17. G. Acs, P.J. Zhang, C.M. McGrath, P. Acs, J. McBroom, and A. Mohyeldin Hypoxia-inducible erythropoietin signaling in squamous dysplasia and squamous cell carcinoma of the uterine cervix and its potential role in cervical carcinogenesis and tumor progression AM J. Pathol. 162 2003 1789 1806
18. F. Pajonk, A. Weil, A. Sommer, R. Suwinski, and M. Henke The erythropoietin-receptor pathway modulates survival of cancer cells Oncogene 23 55 2004 (Nov 25) 8987 8991
19. D. Silver, and S. Piper Effects of recombinant human erythropoietin on the antitumor effect of cisplatin in SCID mice bearing human ovarian cancer: a possible oxygen effect Gynecol. Oncol. 73 2 1999 (May) 280 284
20. Y. Yasuda, T. Musha, H. Tanaka, Y. Fujita, H. Fujita, and H. Utsumi Inhibition of erythropoietin signaling destroys xenografts of ovarian and uterine cancers in nude mice Br. J. Cancer 84 6 2001 (Mar 23) 836 843
21. C. Westenfelder, and R.L. Baranowski Erythropoietin stimulates proliferation of human renal carcinoma cells Kidney Int. 58 2 2000 (Aug) 647 657
22. Y. Yasuda, Y. Fujita, T. Matsuo, S. Koinuma, S. Hara, and A. Tazaki Erythropoietin regulates tumor growth of human malignancies Carcinogenesis 24 6 2003 (Jun) 1021 1029
23. Y. Yasuda, Y. Fujita, S. Masuda, T. Musha, K. Ueda, and H. Tanaka Erythropoietin is involved in growth and angiogenesis in malignant tumors of female reproductive organs Carcinogenesis 23 11 2002 (Nov) 1797 1805
24. B. Leyland-Jones Breast cancer trial with erythropoietin terminated unexpectedly Lancet Oncol. 4 8 2003 (Aug) 459 460
25. M. Henke, R. Laszig, C. Rube, U. Schafer, H. Klaus-Dieter, and S. Burkhard Erythropoietin to treat head and neck cancer patients with anemia undergoing radiotherapy: randomized, double-blind, placebo-controlled trial The Lancet 362 2003 1255 1260
26. P.A. Tilbrook, and S.P. Klinken Erythropoietin and erythropoietin receptor Growth Factors 17 1 1999 25 35
27. G. Acs, P. Acs, S.M. Beckwith, R.L. Pitts, E. Clements, and K. Wong Erythropoietin and erythropoietin receptor expression in human cancer Cancer Res. 61 2001 3561 3565